Edmund Wee

Aug 26, 2024 | mdpi.com | Edmund Wee |Sarah L Kempster |Deborah Ferguson |Joanna Hall

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 1, 2024 | preprints.org | Edmund Wee |Sarah L Kempster |Deborah Ferguson |Joanna Hall

PreprintArticleVersion 1This version is not peer-reviewedVersion 1: Received: 31 July 2024 / Approved: 1 August 2024 / Online: 2 August 2024 (05:12:56 CEST)Wee, E. G.-T.; Kempster, S.; Ferguson, D.; Hall, J.; Ham, C.; Morris, S.; Crook, A.; Gilbert, S. C.; Korber, B.; Almond, N.; Hanke, T. Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-cell Vaccine. Preprints 2024, 2024080038. https://doi.org/10.20944/preprints202408.0038.v1Wee, E.